Trial intelligence / Profile preview

DHEA replacement and vascular function in adrenal insufficiency

2005-000115-10Phase 4Completed

Sponsor
Cardiff University
Start
Sep 2005
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dehydroepiandrosterone in Addison's disease and Adrenocorticotropic hormone (2 arms), sponsored by Cardiff University. Primary endpoints: Arterial stiffness (augmentation index), Arterial stiffness (pulse wave velocity) and 2 more. Started Sep 2005; status: completed.

02

Drugs

dehydroepiandrosterone
03

Conditions

Addison's diseaseAdrenocorticotropic hormone

Beyond the preview

Go deeper on 2005-000115-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000115-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call